BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9612134)

  • 1. [Effects of methylxanthine derivatives on antitumor activity and toxic side effect of adriamycin induced by inhibition of DNA biosynthesis].
    Sadzuka Y; Iwazaki A; Hirota S
    Yakugaku Zasshi; 1998 May; 118(5):179-87. PubMed ID: 9612134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.
    Sadzuka Y; Iwazaki A; Miyagishima A; Nozawa Y; Hirota S
    Jpn J Cancer Res; 1995 Jun; 86(6):594-9. PubMed ID: 7622424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity.
    Kakuyama A; Sadzuka Y
    Curr Drug Metab; 2001 Dec; 2(4):379-95. PubMed ID: 11766989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin.
    Sadzuka Y; Sugiyama T; Miyagishima A; Nozawa Y; Hirota S
    Cancer Lett; 1996 Aug; 105(2):203-9. PubMed ID: 8697445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of caffeine modulation of the antitumor activity of adriamycin.
    Sadzuka Y; Mochizuki E; Takino Y
    Toxicol Lett; 1995 Jan; 75(1-3):39-49. PubMed ID: 7863536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity.
    Sazuka Y; Tanizawa H; Takino Y
    Jpn J Cancer Res; 1989 Oct; 80(10):1000-5. PubMed ID: 2482282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid and adriamycin toxicity.
    Shimpo K; Nagatsu T; Yamada K; Sato T; Niimi H; Shamoto M; Takeuchi T; Umezawa H; Fujita K
    Am J Clin Nutr; 1991 Dec; 54(6 Suppl):1298S-1301S. PubMed ID: 1962586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin.
    Sadzuka Y; Nakai S; Miyagishima A; Nozawa Y; Hirota S
    Cancer Lett; 1997 Jan; 111(1-2):77-86. PubMed ID: 9022131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the cardioprotective effects of docetaxel pre-administration against adriamycin-induced cardiotoxicity.
    Tomonari M; To H; Nishida M; Mishima T; Sasaki H; Kurose H
    J Pharmacol Sci; 2011; 115(3):336-45. PubMed ID: 21358119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline Prevents Driamycin-Induced Myocardial Fibrosis and Apoptosis in Rats.
    Zang Z; Li S; Lin Y; Li X; Li Y; Qin Y; Wang H; Jiang M; Zhu L
    Int Heart J; 2015; 56(6):651-5. PubMed ID: 26549291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tetrahydropyranyladriamycin (THP-ADR) and 4'-epiadriamycin (4'-epi-ADR) on lipid peroxide levels in mice.
    Sadzuka Y; Takino Y
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1329-31. PubMed ID: 1394656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 completely inhibits adriamycin efflux in the adriamycin-resistant strain of Ehrlich ascites tumor cells.
    Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Takeda Y; Hiraki Y
    Anticancer Res; 1996; 16(1):247-50. PubMed ID: 8615615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin.
    Sadzuka Y; Iwazaki A; Sugiyama T; Sawanishi T; Miyamoto K
    Jpn J Cancer Res; 1998 Feb; 89(2):228-33. PubMed ID: 9548452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180.
    Pradhan SG; Chitnis MP; Basrur VS; Tantri SK
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):437-42. PubMed ID: 3609108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine modulates the antitumor activity and toxic side effects of adriamycin.
    Sadzuka Y; Mochizuki E; Takino Y
    Jpn J Cancer Res; 1993 Mar; 84(3):348-53. PubMed ID: 8486534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin.
    Kim C; Kim N; Joo H; Youm JB; Park WS; Cuong DV; Park YS; Kim E; Min CK; Han J
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):200-10. PubMed ID: 16044032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
    Minko T; Kopecková P; Kopecek J
    Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
    Mimnaugh EG; Gram TE; Trush MA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):806-16. PubMed ID: 6411900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamins on lipid peroxidation and suppression of DNA synthesis induced by adriamycin in Ehrlich cells.
    Okamoto K; Ogura R
    J Nutr Sci Vitaminol (Tokyo); 1985 Apr; 31(2):129-37. PubMed ID: 4032070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.